SCHEMBL8309583

SCHEMBL8309583

CC(=O)c1ccc(S(=O)(=O)c2ccccn2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.61
PKM P14618 1/20 0.61
ABCC9 O60706 1/20 0.52
ABCC8 Q09428 1/20 0.52
KCNJ11 Q14654 1/20 0.52
KCNJ8 Q15842 1/20 0.52
MAPT P10636 3/20 0.49
LMNA P02545 3/20 0.49
KMT2A Q03164 2/20 0.49
MAPK1 P28482 1/20 0.49
NAMPT P43490 3/20 0.48
NPC1 O15118 5/20 0.47
RAB9A P51151 5/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
ALDH1A1 P00352 2/20 0.47
CA12 O43570 1/20 0.46
CA9 Q16790 1/20 0.46
MEN1 O00255 1/20 0.46
CYP2C9 P11712 1/20 0.42
POLB P06746 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31108993 0.85 KDM4E (0.63) KDM4EPKMABCC9ABCC8KCNJ11
SCHEMBL8866192 0.84 KDM4E (0.61) KDM4EPKMABCC9ABCC8KCNJ11
SCHEMBL11924742 0.80 IKBKB (0.63)
SCHEMBL7273340 0.80 PKM (0.69) KDM4EPKMABCC9ABCC8KCNJ11
SCHEMBL7459868 0.80 KDM4E (0.69) KDM4EPKMABCC9ABCC8KCNJ11
SCHEMBL8170523 0.79 PKM (0.59) KDM4EPKMABCC9ABCC8KCNJ11
SCHEMBL1573626 0.79 KDM4E (0.72) KDM4EPKMABCC9ABCC8KCNJ11
SCHEMBL27347914 0.77 AGTR1 (0.51) KDM4EPKMMAPTLMNAKMT2A
SCHEMBL5387372 0.77 MAPT (0.73) KDM4EPKMMAPTLMNAKMT2A
SCHEMBL4027167 0.76 MAPT (0.61) KDM4EPKMMAPTLMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1056840-C Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2000-09-27 CN disclosed
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
US-5780490-A A O-(2,4-OXA(OR THIA)ZOLIDINYL)PHENYLOXY(OR THIO OR AMINO) ALKYLOXIME; ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AND -HYPOGLYCEMIC AGENTS; LIVER, SKIN AND UROGENITAL DISORDERS SANKYO COMPANY, LIMITED (JP) 1998-07-14 US disclosed
US-5703096-A ANTIDIABETIC AGENTS; ALDOSE REDUCTASE INHIBITOR SANKYO COMPANY, LIMITED (JP) 1997-12-30 US disclosed
CN-1143639-A Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1997-02-26 CN disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed